UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Mn Services Vermogensbeheer B.V.

Mn Services Vermogensbeheer B.V. lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 6.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 340,000 shares of the healthcare conglomerate's stock after selling 25,300 shares during the period. UnitedHealth Group comprises 1.4% of Mn Services Vermogensbeheer B.V.'s investment portfolio, making the stock its 11th biggest position. Mn Services Vermogensbeheer B.V.'s holdings in UnitedHealth Group were worth $178,075,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently made changes to their positions in the company. Fort Washington Investment Advisors Inc. OH increased its stake in UnitedHealth Group by 0.3% in the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock valued at $277,641,000 after purchasing an additional 1,465 shares during the last quarter. Waycross Partners LLC grew its holdings in shares of UnitedHealth Group by 2.4% during the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate's stock worth $14,060,000 after purchasing an additional 658 shares during the last quarter. Sherbrooke Park Advisers LLC purchased a new position in UnitedHealth Group during the 4th quarter worth approximately $515,000. Full Sail Capital LLC boosted its holdings in shares of UnitedHealth Group by 2.1% in the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock valued at $815,000 after acquiring an additional 33 shares during the period. Finally, Soros Fund Management LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at $39,413,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts have commented on the stock. Royal Bank Of Canada dropped their price objective on shares of UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a research note on Friday, May 16th. Wolfe Research cut their target price on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research note on Tuesday, May 20th. Barclays dropped their price objective on UnitedHealth Group to $350.00 and set an "overweight" rating on the stock in a report on Monday, June 2nd. Raymond James Financial lowered shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research report on Wednesday, May 14th. Finally, Oppenheimer reduced their price objective on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a research note on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the company's stock. According to data from MarketBeat, UnitedHealth Group has an average rating of "Moderate Buy" and an average target price of $426.52.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Kristen Gil bought 3,700 shares of the business's stock in a transaction dated Thursday, May 15th. The shares were acquired at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the purchase, the director now owns 3,818 shares in the company, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director John H. Noseworthy bought 300 shares of the firm's stock in a transaction dated Wednesday, May 14th. The stock was purchased at an average price of $312.16 per share, with a total value of $93,648.00. Following the transaction, the director now owns 6,063 shares in the company, valued at approximately $1,892,626.08. This represents a 5.21% increase in their position. The disclosure for this purchase can be found here. Insiders bought a total of 109,408 shares of company stock valued at $31,607,768 in the last ninety days. Insiders own 0.28% of the company's stock.

UnitedHealth Group Trading Down 0.6%

NYSE:UNH traded down $1.97 on Wednesday, hitting $306.90. 11,134,416 shares of the stock were exchanged, compared to its average volume of 7,282,223. The stock has a fifty day moving average of $376.32 and a 200-day moving average of $469.08. The stock has a market cap of $278.40 billion, a PE ratio of 12.85, a PEG ratio of 1.44 and a beta of 0.44. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The business had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the previous year, the firm posted $6.91 EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.88%. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is presently 37.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.